Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireRead to Know2 months agoWhen Disability Benefits Are Rejected and What Comes NextRead MoreFacebookX.comPinterestLinkedinEmail556110
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals2 months agoHerbert Smith Freehills Kramer advises Squadron Energy on innovative Clarke Creek Wind Farm financingRead MoreFacebookX.comPinterestLinkedinEmail564110
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals2 months agoHSF Kramer advises The Growth Fund on the sale of Black Mount Spring Water and AFS LogisticsRead MoreFacebookX.comPinterestLinkedinEmail566110
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals2 months agoHerbert Smith Freehills Kramer advises Sunstone Development Co on joint venture with Emirates Global AluminiumRead MoreFacebookX.comPinterestLinkedinEmail565110
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals2 months agoSidley Represents Wellington Management in €1.2 Billion Trade Republic Secondary TransactionRead MoreFacebookX.comPinterestLinkedinEmail562110
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals2 months agoSidley Advises UpEnergy on World Bank Clean Cooking Outcome BondRead MoreFacebookX.comPinterestLinkedinEmail569110
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireLaw Firm & In-house Updates2 months agoFirst Chair Trial and Leading Product Liability Lawyer Paul Boehm Joins Sidley as Partner in D.C. to Expand Product Liability and Mass Torts Litigation PracticeRead MoreFacebookX.comPinterestLinkedinEmail800160
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals2 months agoSidley Advises Achieve on Its Inaugural US$217 Million Debt Settlement Fee SecuritizationRead MoreFacebookX.comPinterestLinkedinEmail567110
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals2 months agoSidley Represents Changchun GeneScience (GenSci) Pharmaceuticals in Its Strategic Licensing Agreement With Yarrow Bioscience for First-in-Class Autoimmune Thyroid Disease TherapyRead MoreFacebookX.comPinterestLinkedinEmail566110
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals2 months agoBaker McKenzie Advises HSBC on Parnell Pharmaceutical’s AUD 110,000,000 Noble Pharma Acquisition FinancingRead MoreFacebookX.comPinterestLinkedinEmail573110
